Click in for more news from The Hill{beacon}View Online Health Care Health Care   The Big Story Trump administration orders ...

TrumpRx is aimed at helping patients use their own money to buy medicines. But researchers who study drug pricing warned that ...

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than ...

President Trump launched TrumpRx.gov, a website designed to help Americans purchase prescription drugs directly from manufacturers or pharmacies. While the site aims to lower costs, experts warn many ...

People may be able to pay less for prescriptions with their insurance rather than via the new government website. The Trump ...

GLP-1 weight loss drugs are taking over Super Bowl ads, signaling a major shift in how obesity meds are marketed, normalized ...

Our schools have a great opportunity to decrease weight-based discrimination, prevent eating disorders, and create more inclusive learning environments.

Over the next decade, obesity rates across the nation could surge to close to half of U.S. adults, a new study published in ...

Age-standardized prevalence varied by race and ethnicity group and by sex in 2022, with highest prevalence in non-Hispanic Black women.

The prevalence of obesity is high in the United States and is expected to continue increasing to 46.9 percent of the adult population by 2035.

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

Popular weight-loss drugs like Ozempic and Wegovy can dramatically curb appetite, but experts warn many users are flying blind when it comes to nutrition. New research suggests people taking these ...